Investing.com - Financial Markets Worldwide

Cereno Scientific AB (CRNOSb)

Stockholm
Currency in SEK
9.57
+0.13(+1.38%)
Real-time Data·
CRNOSb Scorecard
Full Analysis
Stock price often moves in the opposite direction of the market
CRNOSb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
9.279.65
52 wk Range
4.7011.90
Key Statistics
Edit
Prev. Close
9.44
Open
9.27
Day's Range
9.27-9.65
52 wk Range
4.7-11.9
Volume
107.59K
Average Volume (3m)
1.34M
1-Year Change
46.36%
Book Value / Share
0.59
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CRNOSb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 11
Analysts do not anticipate the company will be profitable this year
Unlock InvestingPro

Cereno Scientific AB Company Profile

Cereno Scientific AB (publ), a clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden and internationally. The company’s lead drug candidate is CS1, a product candidate that is in phase II clinical trial for the treatment of rare disease pulmonary arterial hypertension, as well as a histone deacetylase (HDAC) inhibitor that acts as an epigenetic modulator with pressure-reducing, reverse-remodeling, anti-inflammatory, anti-fibrotic, and anti-thrombotic properties. Its drugs portfolio includes CS014, an epigenetic modulator that is in phase I for the treatment of cardiovascular, pulmonary diseases, and idiopathic pulmonary fibrosis; and preclinical drug candidates comprises CS585, a selective prostacyclin (IP) receptor agonist for the treatment of rare thrombotic diseases, such as anti phospholipid syndrome. The company has a collaboration agreement with the University of Michigan for the preclinical development program of CS585 and CS014, are preclinical drug candidate for cardiovascular diseases; and Abbott for use of CardioMEMS HF System. Cereno Scientific AB (publ) was incorporated in 2012 and is headquartered in Gothenburg, Sweden.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
10
Market
Sweden

Compare CRNOSb to Peers and Sector

Metrics to compare
CRNOSb
Peers
Sector
Relationship
P/E Ratio
−24.4x−9.6x−0.5x
PEG Ratio
0.39−0.200.00
Price/Book
16.0x6.8x2.6x
Price / LTM Sales
35.2x42.6x3.0x
Upside (Analyst Target)
-17.1%49.2%
Fair Value Upside
Unlock0.5%7.4%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-0.09 / -0.07
Revenue / Forecast
16.42M / --
EPS Revisions
a
a
Unlock
Last 90 days

CRNOSb Income Statement

People Also Watch

Sinch AB
29.06
SINCH
+0.07%
Samhallsbyggnadsbolaget
5.05
SBBb
-1.44%
Dicot
0.511
DICOT
-1.73%
Evolution AB
750.60
EVOG
-0.13%

FAQ

What Is the Cereno Scientific (CRNOSb) Stock Price Today?

The Cereno Scientific stock price today is 9.57

What Stock Exchange Does Cereno Scientific Trade On?

Cereno Scientific is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Cereno Scientific?

The stock symbol for Cereno Scientific is "CRNOSb."

What Is the Cereno Scientific Market Cap?

As of today, Cereno Scientific market cap is 2.68B.

What Is Cereno Scientific's Earnings Per Share (TTM)?

The Cereno Scientific EPS (TTM) is -0.37.

When Is the Next Cereno Scientific Earnings Date?

Cereno Scientific will release its next earnings report on Aug 27, 2025.

From a Technical Analysis Perspective, Is CRNOSb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Cereno Scientific Stock Split?

Cereno Scientific has split 0 times.

How Many Employees Does Cereno Scientific Have?

Cereno Scientific has 10 employees.

What is the current trading status of Cereno Scientific (CRNOSb)?

As of Jul 08, 2025, Cereno Scientific (CRNOSb) is trading at a price of 9.57, with a previous close of 9.44. The stock has fluctuated within a day range of 9.27 to 9.65, while its 52-week range spans from 4.70 to 11.90.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.